FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Imprimis NJOF Epinephrine-Lidocaine HCl Recall

Epinephrine-Lidocaine HCl (0

Imprimis NJOF, LLC · Ledgewood, NJ

Risk level
Class III
Reported by FDA
Oct 11, 2023
Recall ID
D-0040-2024
Check your lot numberHow we source this data

Summary

Imprimis NJOF recalled Epinephrine-Lidocaine HCl starting Oct 3, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0040-2024 on Oct 11, 2023. Reason: Subpotent: Failing Test Results for Epinephrine. Status: Terminated.

Why it was recalled

Subpotent: Failing Test Results for Epinephrine

Product description

Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979

Lot numbers, UPCs & expiration codes

23APR018

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0040-2024
Classification
Class III
Status
Terminated
Recall initiated
Oct 3, 2023
FDA report date
Oct 11, 2023
Quantity
364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)
Recall type
Voluntary: Firm initiated
Recalling firm
Imprimis NJOF, LLC

Original FDA data

Every field from FDA enforcement report D-0040-2024, exactly as published.

Show all FDA fields
City
Ledgewood
State
NJ
Status
Terminated
Country
United States
Event ID
93160
Address
1705 Route 46 Ste 6B
Code information
23APR018
Postal code
07852-9720
Report date
Oct 11, 2023
Product type
Drugs
Recall number
D-0040-2024
Classification
Class III
Recalling firm
Imprimis NJOF, LLC
Product quantity
364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)
Termination date
Mar 21, 2025
Reason for recall
Subpotent: Failing Test Results for Epinephrine
Voluntary / mandated
Voluntary: Firm initiated
Product description
Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979
Distribution pattern
Nationwide
Recall initiation date
Oct 3, 2023
Initial firm notification
Letter
Center classification date
Oct 5, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0040-2024, published Oct 11, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls